Noteworthily, stable transfection with an ion translocation-defective NHE1 reduces both gene expression and activity of MMP9 [119], and in breast cancer cells, NHE1 inhibition blocks the CD44-dependent increase in cathepsin B maturation and activity [10]. This evidence concerns the gene SLC9A1 and breast carcinoma.